Withings BPM Pro 2: Award-winning new blood pressure monitor now FDA-approved

The Withings BPM Pro 2, a cellular blood pressure monitor, has been cleared by the FDA. Withings claims that this is the first device of its kind, providing remote patient monitoring for medical professionals.

The BPM Pro 2 was revealed in October when the company announced that it was seeking FDA clearance before it launched the device. It is worth noting that Withings is still awaiting FDA approval for its 1-lead ECG for atrial fibrillation detection, a feature which is expected to launch in 2025. Features of the BPM Pro 2 include the ability for patients to measure diastolic and systolic blood pressure as well as pulse rate at home. Plus, there are Patient Insights questionnaires to gain context on the data and the ability to prompt a user to retake a measurement.

The Withings BPM Pro 2 is now available to be purchased by healthcare professionals; the price of the product has not been publicly announced. In other recent news, the company has announced that the BPM Pro 2 is a CES 2025 Innovation Awards Honoree in the Digital Health category. If you are looking for a consumer blood pressure monitor, Withings offers the BPM Connect, currently $90.32 at Amazon.